Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Lispro 50 vs Lispro 25 in Chinese adults with type 2 diabetes on basal insulin
ChiCTR2000036872Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Aug 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin lispro protamine + insulin lispro and biphasic insulin lispro in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Change in HbA1c from baseline at week 16. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
insulin lispro protamine + insulin lisprobiphasic insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000036872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036872.